HomePCSA • NASDAQ
add
Processa Pharmaceuticals Inc
Previous close
$3.01
Day range
$3.28 - $8.88
Year range
$2.75 - $27.00
Market cap
379.01M USD
Avg Volume
84.71K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.49M | 1.87% |
Net income | -3.44M | -1.53% |
Net profit margin | — | — |
Earnings per share | -1.75 | 93.20% |
EBITDA | -3.49M | -1.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.31M | 118.17% |
Total assets | 7.58M | 53.47% |
Total liabilities | 1.75M | 43.36% |
Total equity | 5.83M | — |
Shares outstanding | 56.64M | — |
Price to book | 27.32 | — |
Return on assets | -110.64% | — |
Return on capital | -145.78% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.44M | -1.53% |
Cash from operations | -3.48M | 3.28% |
Cash from investing | — | — |
Cash from financing | 2.86M | 208.38% |
Net change in cash | -628.20K | 76.56% |
Free cash flow | -2.24M | 5.37% |
About
Founded
2011
Headquarters
Website
Employees
10
